Skip to main content

Advertisement

SpringerLink
Log in

The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II

  • Invited Review
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

Taurine, a ubiquitous endogenous sulfur-containing amino acid, possesses numerous pharmacological and physiological actions, including antioxidant activity, modulation of calcium homeostasis and antiapoptotic effects. There is mounting evidence supporting the utility of taurine as a pharmacological agent against heart disease, including chronic heart failure (CHF). In the past decade, angiotensin II blockade and β-adrenergic inhibition have served as the mainstay in the treatment of CHF. Both groups of pharmaceutical agents decrease mortality and improve the quality of life, a testament to the critical role of the sympathetic nervous system and the renin--angiotensin system in the development of CHF. Taurine has also attracted attention because it has beneficial actions in CHF, in part by its demonstrated inhibition of the harmful actions of the neurohumoral factors. In this review, we summarize the beneficial actions of taurine in CHF, focusing on its antagonism of the catecholamines and angiotensin II.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Abe M, Shibata K, Matsuda T, Furukawa T (1987) Inhibition of hypertension and salt intake by oral taurine treatment in hypertensive rats. Hypertension 10:383–389

    Article  CAS  PubMed  Google Scholar 

  • Abe M, Tokunaga T, Yamada K, Furukawa T (1988) Gamma-aminobutyric acid and taurine antagonize the central effects of angiotensin II and renin on the intake of water and salt, and on blood pressure in rats. Neuropharmacology 27:309–318

    Article  CAS  PubMed  Google Scholar 

  • Abebe W, Mozaffari MS (2011) Role of taurine in the vasculature: an overview of experimental and human studies. Am J Cardiovasc Dis 1:293–311

    CAS  PubMed Central  PubMed  Google Scholar 

  • Azuma J, Hasegawa H, Sawamura A, Awata N, Harada H, Ogura K, Kishimoto S (1982) Taurine for treatment of congestive heart failure. Int J Cardiol 2:303–304

    Article  CAS  PubMed  Google Scholar 

  • Azuma J, Hasegawa H, Sawamura A, Awata N, Ogura K, Harada H, Yamamura Y, Kishimoto S (1983) Therapy of congestive heart failure with orally administered taurine. Clin Ther 5:398–408

    CAS  PubMed  Google Scholar 

  • Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H, Takihara K, Hasegawa H, Yamagami T, Ishiyama T et al (1985) Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 8:276–282

    Article  CAS  PubMed  Google Scholar 

  • Azuma J, Hamaguchi T, Ohta H, Takihara K, Awata N, Sawamura A, Harada H, Tanaka Y, Kishimoto S (1987) Calcium overload-induced myocardial damage caused by isoproterenol and by adriamycin: possible role of taurine in its prevention. Adv Exp Med Biol 217:167–179

    Article  CAS  PubMed  Google Scholar 

  • Azuma J, Katsume H, Kagisgima T, Furukawa K, Awata N, Ishiyama T, Yamagami T, Ishikawa H, Iwata H, Kishimoto S et al (1989) Clinical evaluation of taurine in congestive heart failure—a double-blind comparative study using CoQ10 as a control drug. In: Iwata H, Lombardini JB, Segawa T (eds) Taurine and the heart. Kluwer Academic Publishers, Boston, pp 75–97

    Chapter  Google Scholar 

  • Azuma J, Sawamura A, Awata N (1992) Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 56:95–99

    Article  CAS  PubMed  Google Scholar 

  • Azuma M, Takahashi K, Fukuda T, Ohyabu Y, Yamamoto I, Kim S, Iwao H, Schaffer SW, Azuma J (2000) Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes. Eur J Pharmacol 403:181–188

    Article  CAS  PubMed  Google Scholar 

  • Ballard-Croft C, Mozaffari MS, Azuma J, Schaffer S (1997) Interaction between taurine and angiotensin II: modulation of calcium transport and myocardial contractile function. Amino Acids 13:105–114

    Article  CAS  Google Scholar 

  • Beyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA (2011) Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol 57:333–337

    Article  PubMed  Google Scholar 

  • Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358:2148–2159

    Article  CAS  PubMed  Google Scholar 

  • Braunwald E, Bristow MR (2000) Congestive heart failure: fifty years of progress. Circulation 102:IV14–IV23

    CAS  PubMed  Google Scholar 

  • Carr AC, McCall MR, Frei B (2000) Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 20:1716–1723

    Article  CAS  PubMed  Google Scholar 

  • Chovan JP, Kulakowski EC, Sheakowski S, Schaffer SW (1980) Calcium regulation of low-affinity taurine binding sites of cardiac sarcolemma. Mol Pharmacol 17:295–300

    CAS  PubMed  Google Scholar 

  • Colucci WS (1998) The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure. Clin Cardiol 21:I20–I24

    Article  CAS  PubMed  Google Scholar 

  • Crass MF III, Lombardini JB (1977) Loss of cardiac muscle taurine after acute left ventricular ischemia. Life Sci 21:951–958

    Article  CAS  PubMed  Google Scholar 

  • Cruz CI, Ruiz-Torres P, del Moral RG, Rodriguez-Puyol M, Rodriguez-Puyol D (2000) Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am J Physiol Renal Physiol 278:F122–F129

    CAS  PubMed  Google Scholar 

  • Denipote F, Ardisson LP, Azevedo PS, Minicucci MF, Lima-Leopoldo AP, Chiuso-Minicucci F, Polegato BF, Matsubara BB, Matsubara LS, Novelli E et al (2011) Influence of taurine on cardiac remodeling induced by tobacco smoke exposure. Cell Physiol Biochem 27:291–298

    Article  CAS  PubMed  Google Scholar 

  • Dhalla NS, Adameova A, Kaur M (2010) Role of catecholamine oxidation in sudden cardiac death. Fundam Clin Pharmacol 24:539–546

    Article  CAS  PubMed  Google Scholar 

  • Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN (1984) The neurohumoral axis in congestive heart failure. Ann Intern Med 101:370–377

    Article  CAS  PubMed  Google Scholar 

  • Franconi F, Giotti A, Manzini S, Martini F, Stendardi I, Zilletti L (1982) The effect of taurine on high potassium- and noradrenaline-induced contraction in rabbit ear artery. Br J Pharmacol 75:605–612

    Article  CAS  PubMed  Google Scholar 

  • Fujita T, Ando K, Noda H, Ito Y, Sato Y (1987) Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75:525–532

    Article  CAS  PubMed  Google Scholar 

  • Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500–508

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gomes da Silva AQ, Xavier CH, Campagnole-Santos MJ, Caligiorne SM, Baltatu OC, Bader M, Santos RA, Fontes MA (2012) Cardiovascular responses evoked by activation or blockade of GABA(A) receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen. Brain Res 1448:101–110

    Article  CAS  PubMed  Google Scholar 

  • Hamaguchi T, Azuma J, Awata N, Ohta H, Takihara K, Harada H, Kishimoto S, Sperelakis N (1988) Reduction of doxorubicin-induced cardiotoxicity in mice by taurine. Res Commun Chem Pathol Pharmacol 59:21–30

    CAS  PubMed  Google Scholar 

  • Hanna J, Chahine R, Aftimos G, Nader M, Mounayar A, Esseily F, Chamat S (2004) Protective effect of taurine against free radicals damage in the rat myocardium. Exp Toxicol Pathol 56:189–194

    Article  CAS  PubMed  Google Scholar 

  • Hano T, Kasano M, Tomari H, Iwane N (2009) Taurine suppresses pressor response through the inhibition of sympathetic nerve activity and the improvement in baro-reflex sensitivity of spontaneously hypertensive rats. Adv Exp Med Biol 643:57–63

    Article  CAS  PubMed  Google Scholar 

  • Hansen SH, Andersen ML, Cornett C, Gradinaru R, Grunnet N (2010) A role for taurine in mitochondrial function. J Biomed Sci 17(Suppl 1):S23

    Article  PubMed  Google Scholar 

  • Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ (2005) Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45:1832–1839

    Article  CAS  PubMed  Google Scholar 

  • Huxtable R, Bressler R (1974) Taurine concentrations in congestive heart failure. Science 184:1187–1188

    Article  CAS  PubMed  Google Scholar 

  • Ito T, Azuma J (2012) Taurine depletion-related cardiomyopathy in animals. In: Veselka J (ed) Cardiomyopathies—from basic research to clinical management. doi:10.5772/30023. ISBN 978-953-307-834-2

  • Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M et al (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937

    Article  CAS  PubMed  Google Scholar 

  • Jeejeebhoy F, Keith M, Freeman M, Barr A, McCall M, Kurian R, Mazer D, Errett L (2002) Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 143:1092–1100

    Article  CAS  PubMed  Google Scholar 

  • Jong CJ, Azuma J, Schaffer S (2012) Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 42:2223–2232

    Article  CAS  PubMed  Google Scholar 

  • Kramer JH, Chovan JP, Schaffer SW (1981) Effect of taurine on calcium paradox and ischemic heart failure. Am J Physiol 240:H238–H246

    CAS  PubMed  Google Scholar 

  • Landmesser U, Wollert KC, Drexler H (2009) Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc Res 81:519–527

    Article  CAS  PubMed  Google Scholar 

  • Li N, Sawamura M, Nara Y, Ikeda K, Yamori Y (1996) Direct inhibitory effects of taurine on norepinephrine-induced contraction in mesenteric artery of stroke-prone spontaneously hypertensive rats. Adv Exp Med Biol 403:257–262

    Article  CAS  PubMed  Google Scholar 

  • Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, Hu D, Huang K, Wang Y, Wang X et al (2005) Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression. Cardiovasc Drugs Ther 19:105–112

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Arnold JM, Pampillo M, Babwah AV, Peng T (2009) Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free Radical Biol Med 46:51–61

    Article  CAS  Google Scholar 

  • Ling H, Zhang T, Pereira L, Means CK, Cheng H, Gu Y, Dalton ND, Peterson KL, Chen J, Bers D et al (2009) Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119:1230–1240

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Liu Y, Niu L, Zhang W, Cui L, Zhang X, Liang Y, Zhang M (2009) Effects of taurine on contractions of the porcine coronary artery. Pharmacol Rep 61:681–689

    CAS  PubMed  Google Scholar 

  • Marcinkiewicz J, Kontny E (2012) Taurine and inflammatory diseases. Amino acids [Epub ahead of print]

  • Marcinkiewicz J, Chain B, Nowak B, Grabowska A, Bryniarski K, Baran J (2000) Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm Res 49:280–289

    Article  CAS  PubMed  Google Scholar 

  • McBroom MJ, Welty JD (1977) Effects of taurine on heart calcium in the cardiomyopathic hamster. J Mol Cell Cardiol 9:853–858

    Article  CAS  PubMed  Google Scholar 

  • Militante JD, Lombardini JB (2002) Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23:381–393

    Article  CAS  PubMed  Google Scholar 

  • Mizushima S, Nara Y, Sawamura M, Yamori Y (1996) Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 403:615–622

    Article  CAS  PubMed  Google Scholar 

  • Moise NS, Pacioretty LM, Kallfelz FA, Stipanuk MH, King JM, Gilmour RF (1991) Dietary taurine deficiency and dilated cardiomyopathy in the fox. Am Heart J 121:541–547

    Article  CAS  PubMed  Google Scholar 

  • Mozaffari MS, Miyata N, Schaffer SW (2003) Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat. Am J Hypertens 16:673–680

    Article  CAS  PubMed  Google Scholar 

  • Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98:794–799

    Article  CAS  PubMed  Google Scholar 

  • Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, Yamamoto M, Miyaji K, Saito H, Morita H et al (2002) Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105:2867–2871

    Article  CAS  PubMed  Google Scholar 

  • Nishida S, Satoh H (2009) Vascular modulation of rat aorta by taurine. Adv Exp Med Biol 643:37–46

    Article  CAS  PubMed  Google Scholar 

  • Niu LG, Zhang MS, Liu Y, Xue WX, Liu DB, Zhang J, Liang YQ (2008) Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries. Eur J Pharmacol 580:169–174

    Article  CAS  PubMed  Google Scholar 

  • Novotny MJ, Hogan PM, Flannigan G (1994) Echocardiographic evidence for myocardial failure induced by taurine deficiency in domestic cats. Can J Vet Res-Revue Canadienne De Recherche Veterinaire 58:6–12

    CAS  Google Scholar 

  • Ohta H, Azuma J, Onishi S, Awata N, Takihara K, Kishimoto S (1986) Protective effect of taurine against isoprenaline-induced myocardial damage. Basic Res Cardiol 81:473–481

    Article  CAS  PubMed  Google Scholar 

  • Ohta H, Azuma J, Awata N, Hamaguchi T, Tanaka Y, Sawamura A, Kishimoto S, Sperelakis N (1988) Mechanism of the protective action of taurine against isoprenaline induced myocardial damage. Cardiovasc Res 22:407–413

    Article  CAS  PubMed  Google Scholar 

  • Oliveira MW, Minotto JB, de Oliveira MR, Zanotto-Filho A, Behr GA, Rocha RF, Moreira JC, Klamt F (2010) Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen species. Pharmacol Rep 62:185–193

    CAS  PubMed  Google Scholar 

  • Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH (2004) Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 109:1877–1885

    Article  CAS  PubMed  Google Scholar 

  • Pansani MC, Azevedo PS, Rafacho BP, Minicucci MF, Chiuso-Minicucci F, Zorzella-Pezavento SG, Marchini JS, Padovan GJ, Fernandes AA, Matsubara BB et al (2012) Atrophic cardiac remodeling induced by taurine deficiency in Wistar rats. PLoS ONE 7:e41439

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pasantes-Morales H, Chatagner F, Mandel P (1980) Synthesis of taurine in rat liver and brain in vivo. Neurochem Res 5:441–451

    Article  CAS  PubMed  Google Scholar 

  • Patel KP, Zheng H (2012) Central neural control of sympathetic nerve activity in heart failure following exercise training. Am J Physiol Heart Circ Physiol 302:H527–H537

    Article  CAS  PubMed  Google Scholar 

  • Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine—a reversible cardiomyopathy. Science 237:764–768

    Article  CAS  PubMed  Google Scholar 

  • Rana SK, Sanders TA (1986) Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores. Br J Nutr 56:17–27

    Article  CAS  PubMed  Google Scholar 

  • Raschke P, Massoudy P, Becker BF (1995) Taurine protects the heart from neutrophil-induced reperfusion injury. Free Radic Biol Med 19:461–471

    Article  CAS  PubMed  Google Scholar 

  • Reid IA (1992) Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262:E763–E778

    CAS  PubMed  Google Scholar 

  • Ricci C, Pastukh V, Leonard J, Turrens J, Wilson G, Schaffer D, Schaffer SW (2008) Mitochondrial DNA damage triggers mitochondrial superoxide generation and apoptosis. Am J Physiol 294:C413–C422

    Article  CAS  Google Scholar 

  • Ristori MT, Verdetti J (1991) Effects of taurine on rat aorta in vitro. Fundam Clin Pharmacol 5:245–258

    Article  CAS  PubMed  Google Scholar 

  • Ritter O, Neyses L (2003) The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med 9:313–321

    Article  CAS  PubMed  Google Scholar 

  • Rosenkranz S (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423–432

    Article  CAS  PubMed  Google Scholar 

  • Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K et al (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16:470–474

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sato Y, Ando K, Fujita T (1987) Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats. Hypertension 9:81–87

    Article  CAS  PubMed  Google Scholar 

  • Satoh H, Sperelakis N (1998) Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol 30:451–463

    Article  CAS  PubMed  Google Scholar 

  • Sawamura A, Azuma J, Harada H, Hasegawa H, Ogura K, Sperelakis N, Kishimoto S (1983) Protection by oral pretreatment with taurine against the negative inotropic effects of low-calcium medium on isolated perfused chick heart. Cardiovasc Res 17:620–626

    Article  CAS  PubMed  Google Scholar 

  • Sawamura A, Sada H, Azuma J, Kishimoto S, Sperelakis N (1990) Taurine modulates ion influx through cardiac Ca2+ channels. Cell Calcium 11:251–259

    Article  CAS  PubMed  Google Scholar 

  • Schaffer SW, Ballard-Croft C, Takahashi K, Azuma J (1998) Effect of taurine depletion on angiotensin II-mediated modulation of myocardial function. Adv Exp Med Biol 442:145–152

    Article  CAS  PubMed  Google Scholar 

  • Schaffer SW, Lombardini JB, Azuma J (2000a) Interaction between the actions of taurine and angiotensin II. Amino Acids 18:305–318

    Article  CAS  PubMed  Google Scholar 

  • Schaffer S, Solodushko V, Azuma J (2000b) Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress. Adv Exp Med Biol 483:57–69

    Article  CAS  PubMed  Google Scholar 

  • Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91–99

    Article  CAS  PubMed  Google Scholar 

  • Schaffer SW, Jong CJ, Ramila KC, Azuma J (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17(Suppl 1):S2

    Article  PubMed  Google Scholar 

  • Schaffer SW, Jong CJ, Warner D, Ito T, Azuma J (2013) Taurine deficiency and MELAS are closely related syndromes. Adv Exp Med Biol 776:153–165

    Article  CAS  PubMed  Google Scholar 

  • Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202

    Article  CAS  PubMed  Google Scholar 

  • Shao A, Hathcock JN (2008) Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regul Toxicol Pharmacol 50:376–399

    Article  CAS  PubMed  Google Scholar 

  • Sharov VS, Dremina ES, Galeva NA, Williams TD, Schöneich C (2006) Quantitative mapping of oxidation-sensitive cysteine residues of SERCA in vivo and in vitro by HPLC electrospray-tandem MS: selective protein modification during biological aging. Biochem J 394:605–615

    Article  CAS  PubMed  Google Scholar 

  • Shi Y, Ducharme A, Li D, Gaspo R, Nattel S, Tardif JC (2001) Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 52:217–225

    Article  CAS  PubMed  Google Scholar 

  • Shi YR, Bu DF, Qi YF, Gao L, Jiang HF, Pang YZ, Tang CS, Du JB (2002) Dysfunction of myocardial taurine transport and effect of taurine supplement in rats with isoproterenol-induced myocardial injury. Acta Pharmacol Sin 23:910–918

    CAS  PubMed  Google Scholar 

  • Shiny KS, Kumar SH, Farvin KH, Anandan R, Devadasan K (2005) Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. J Pharm Pharmacol 57:1313–1317

    Article  CAS  PubMed  Google Scholar 

  • Sirker A, Zhang M, Murdoch C, Shah AM (2007) Involvement of NADPH oxidases in cardiac remodeling and heart failure. Am J Nephrol 27:649–660

    Article  CAS  PubMed  Google Scholar 

  • Stipanuk MH, Ueki I, Dominy JE Jr, Simmons CR, Hirschberger LL (2009) Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels. Amino Acids 37:55–63

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Suzuki T, Wada T, Saigo K, Watanabe K (2002) Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J 21:6581–6589

    Article  CAS  PubMed  Google Scholar 

  • Takahashi K, Azuma M, Taira K, Baba A, Yamamoto I, Schaffer SW, Azuma J (1997) Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J Cardiovasc Pharmacol 30:725–730

    Article  CAS  PubMed  Google Scholar 

  • Takihara K, Azuma J, Awata N, Ohta H, Hamaguchi T, Sawamura A, Tanaka Y, Kishimoto S, Sperelakis N (1986) Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J 112:1278–1284

    Article  CAS  PubMed  Google Scholar 

  • Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241–248

    Article  CAS  PubMed  Google Scholar 

  • Tang WH, Brennan ML, Philip K, Tong W, Mann S, Van Lente F, Hazen SL (2006) Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 98:796–799

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto J, Akabane S, Yoshimi H, Nakai M, Ikeda M (1985) Effects of taurine on stress-evoked hemodynamic and plasma catecholamine changes in spontaneously hypertensive rats. Hypertension 7:913–922

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi-Takihara K, Azuma J, Kishimoto S, Onishi S, Sperelakis N (1988) Taurine prevention of calcium paradox-related damage in cardiac muscle. Its regulatory action on intracellular cation contents. Biochem Pharmacol 37:2651–2658

    Article  CAS  PubMed  Google Scholar 

  • Zelis R, Mason DT, Braunwald E (1968) A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 47:960–970

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zucker IH (2006) Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48:1005–1011

    Article  CAS  PubMed  Google Scholar 

  • Zulli A (2011) Taurine in cardiovascular disease. Curr Opin Clin Nutr Metab Care 14:57–60

    Article  CAS  PubMed  Google Scholar 

  • Zulli A, Lau E, Wijaya BP, Jin X, Sutarga K, Schwartz GD, Learmont J, Wookey PJ, Zinellu A, Carru C et al (2009) High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension 53:1017–1022

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This review work is supported from Grants-in-Aid from the Ministry of Health, Labor and Welfare and from the Ministry of Education, Science, Sports and Culture of Japan. This work is also supported by a research grant from Taisho Pharmaceutical Co. Ltd. (Japan).

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacogenomics, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Hyogo, Japan

    Takashi Ito & Junichi Azuma

  2. Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, AL, USA

    Stephen Schaffer

Authors
  1. Takashi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Schaffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junichi Azuma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junichi Azuma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, T., Schaffer, S. & Azuma, J. The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. Amino Acids 46, 111–119 (2014). https://doi.org/10.1007/s00726-013-1507-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-013-1507-z

Keywords

Search

Navigation